Related Experiment Video
Updated: Dec 9, 2025

Generation of 3D Whole Lung Organoids from Induced Pluripotent Stem Cells for Modeling Lung Developmental Biology and Disease
Published on: April 12, 2021
Organoids Model Transcriptional Hallmarks of Oncogenic KRAS Activation in Lung Epithelial Progenitor Cells
Antonella F M Dost1, Aaron L Moye1, Marall Vedaie2
1Stem Cell Program and Divisions of Hematology/Oncology and Pulmonary Medicine, Boston Children's Hospital, Boston, MA 02115, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA; Department of Genetics, Harvard Medical School, Boston, MA 02115, USA.
Abstract:
Mutant KRAS is a common driver in epithelial cancers. Nevertheless, molecular changes occurring early after activation of oncogenic KRAS in epithelial cells remain poorly understood. We compared transcriptional changes at single-cell resolution after KRAS activation in four sample sets. In addition to patient samples and genetically engineered mouse models, we developed organoid systems from primary mouse and human induced pluripotent stem cell-derived lung epithelial cells to model early-stage lung adenocarcinoma. In all four settings, alveolar epithelial progenitor (AT2) cells expressing oncogenic KRAS had reduced expression of mature lineage identity genes. These findings demonstrate the utility of our in vitro organoid approaches for uncovering the early consequences of oncogenic KRAS expression. This resource provides an extensive collection of datasets and describes organoid tools to study the transcriptional and proteomic changes that distinguish normal epithelial progenitor cells from early-stage lung cancer, facilitating the search for targets for KRAS-driven tumors.
Insights
Activating KRAS mutations in epithelial cancers cause early molecular changes. Our study used organoid models to show oncogenic KRAS reduces mature cell identity genes in lung adenocarcinoma progenitor cells.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Mutant KRAS is a key driver in many epithelial cancers.
- Early molecular events following oncogenic KRAS activation are not well understood.
- Understanding these early changes is crucial for developing targeted therapies.
Purpose of the Study:
- To investigate the early transcriptional consequences of oncogenic KRAS activation in epithelial cells.
- To develop and validate organoid models for studying early-stage lung adenocarcinoma.
- To identify molecular changes distinguishing normal progenitor cells from early cancer cells.
Main Methods:
- Single-cell RNA sequencing to analyze transcriptional changes.
- Comparison across four distinct sample sets: patient samples, mouse models, and two organoid systems (mouse and human iPSC-derived).
- Development of in vitro organoid models from lung epithelial progenitor cells.
Main Results:
- Consistent transcriptional alterations were observed across all four tested settings.
- Alveolar epithelial progenitor (AT2) cells with oncogenic KRAS showed decreased expression of mature lineage identity genes.
- The study generated extensive datasets and organoid tools for further research.
Conclusions:
- In vitro organoid models are effective for studying early oncogenic KRAS effects.
- Oncogenic KRAS activation impacts epithelial progenitor cell identity.
- This work provides resources to identify therapeutic targets for KRAS-driven cancers.
Related Concept Videos
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Ras Gene
Ras is a...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

